Dark Hacker News
new
|
best
|
ask
|
show
|
jobs
aaavl2821 | Dark Hacker News
user:
aaavl2821
created:
November 21, 2017
karma:
3.0k
about:
biopharma and healthcare baybridgebio.com
richard at baybridgebio.com
submissions
comments
1.
Sophistical Refutations
(en.wikipedia.org)
1 points
by
aaavl2821
227 days ago
|
0 comments
2.
Sophist
(en.wikipedia.org)
15 points
by
aaavl2821
228 days ago
|
5 comments
3.
Can AI predict clinical trial outcomes?
(baybridgebio.com)
2 points
by
aaavl2821
339 days ago
|
0 comments
4.
AI won't replace biotech analysts
(baybridgebio.com)
1 points
by
aaavl2821
340 days ago
|
0 comments
5.
Show HN: Research Pharma Markets with AI
(baybridgebio.com)
2 points
by
aaavl2821
1 year ago
|
0 comments
6.
Show HN: Search for drugs approved to treat a given disease
(baybridgebio.com)
1 points
by
aaavl2821
1 year ago
|
0 comments
7.
Better obesity drugs are coming soon
(baybridgebio.com)
2 points
by
aaavl2821
1 year ago
|
0 comments
8.
The Future of the Obesity Market
(baybridgebio.com)
1 points
by
aaavl2821
1 year ago
|
0 comments
9.
The obesity drug landscape in one chart
(baybridgebio.com)
3 points
by
aaavl2821
1 year ago
|
0 comments
10.
A primer on the obesity drug landscape
(baybridgebio.com)
2 points
by
aaavl2821
1 year ago
|
0 comments
11.
AI-enabled biotech startup analysis
(baybridgebio.com)
1 points
by
aaavl2821
2 years ago
|
0 comments
12.
Analyzing gene therapy startup in layman's terms
(baybridgebio.com)
1 points
by
aaavl2821
2 years ago
|
0 comments
13.
AI Analysis of Biotech Startups
(baybridgebio.com)
2 points
by
aaavl2821
2 years ago
|
0 comments
14.
AI investment analyst: initiating coverage on Neumora Therapeutics
(baybridgebio.com)
1 points
by
aaavl2821
2 years ago
|
0 comments
15.
Quantifying risk / reward in biotech investing
(baybridgebio.com)
1 points
by
aaavl2821
2 years ago
|
0 comments
16.
Valuing Biotech Licensing Deals
(baybridgebio.com)
1 points
by
aaavl2821
2 years ago
|
0 comments
17.
Show HN: Value Biotech Licensing Deals
(baybridgebio.com)
2 points
by
aaavl2821
2 years ago
|
0 comments
18.
Which VCs are still investing in biopharma?
(baybridgebio.com)
1 points
by
aaavl2821
3 years ago
|
0 comments
19.
Biotech VC on pace for worst year since 2016
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments
20.
The biotech venture capital crunch
(baybridgebio.com)
1 points
by
aaavl2821
3 years ago
|
0 comments
21.
1 points
by
aaavl2821
3 years ago
|
discuss
22.
Show HN: Interactive guide to valuing biotech companies
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments
23.
Diagnosing the problem with biotech R&D
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments
24.
Is Biotech Investing Sustainable?
(baybridgebio.com)
1 points
by
aaavl2821
3 years ago
|
0 comments
25.
The next generation of biotech VCs
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments
26.
Will a Recession Save Biotech?
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments
27.
Biotech platforms are out, products are back in
(baybridgebio.com)
16 points
by
aaavl2821
3 years ago
|
2 comments
28.
Bargain hunting for biotech stocks [video]
(youtube.com)
1 points
by
aaavl2821
3 years ago
|
0 comments
29.
Can big pharma buy every biotech startup?
(baybridgebio.com)
1 points
by
aaavl2821
3 years ago
|
0 comments
30.
Biotech crossover investors facing steep losses
(baybridgebio.com)
2 points
by
aaavl2821
3 years ago
|
0 comments